Background: Tumor ablation is often employed for unresectable colorectal liver metastases. However, no survival benefit has ever been demonstrated in prospective randomized studies. Here, we investigate the long-term benefits of such an aggressive approach. Methods: In this randomized phase II trial...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!